Schedule 13G ownership disclosure

BIO BLAST PHARMA LTD.

Security class unavailable · CUSIP: M20156101

Event date: 2016-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,011,130
Percent of class
6.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000142
Form type
SC 13G
Filer
Enlivex Ltd.
CIK
CIK 1596812
Filed
Mar 23, 2016
Reporting period
Mar 17, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub